共 88 条
[1]
Altman RA(2000)Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update Arthritis Rheum. 43 1905-1915
[2]
Hochberg MC(2004)Clinical pharmacology of tramadol Clin Pharmacokinet. 43 879-923
[3]
Moskowitz RW(1999)Analgesic efficacy and tolerability of tramadol 100 mg sustained release capsules in patients with moderate to severe chronic low back pain Clin Drug Invest. 17 415-423
[4]
Schnitzer TJ(2005)Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain J Clin Pharm Ther. 30 113-120
[5]
Grond S(2004)Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study Clin Ther. 26 1774-1782
[6]
Sablotzki A(2004)Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee J Pain Symptom Manage. 28 59-71
[7]
Raber M(2003)Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system AAPS PharmSciTech. 4 E31-E31
[8]
Hoffman S(2001)Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenate Eur J Pharm Biopharm. 52 231-235
[9]
Junge K(2000)In vitro/in vivo characterization of a tramadol HCl depot system composed of monoolein and water Biol Pharm Bull. 23 627-631
[10]
Momberger H(2000)Microencapsulation and characterization of tramadol-resin complexes J Control Release. 66 107-113